Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
504
-
Total 13F shares, excl. options
-
72M
-
Shares change
-
+87.3K
-
Total reported value, excl. options
-
$29.6B
-
Value change
-
+$118M
-
Put/Call ratio
-
1.33
-
Number of buys
-
223
-
Number of sells
-
-231
-
Price
-
$410.25
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2014
586 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2014.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 504 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72M shares
of 105M outstanding shares and own 68.61% of the company stock.
Largest 10 shareholders include Capital World Investors (7.88M shares), FMR LLC (6.69M shares), WELLINGTON MANAGEMENT GROUP LLP (5.88M shares), SANDS CAPITAL MANAGEMENT, LLC (4.99M shares), VANGUARD GROUP INC (4.01M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.94M shares), State Street Corp (3.19M shares), Artisan Partners Limited Partnership (2.3M shares), BlackRock Institutional Trust Company, N.A. (1.99M shares), and BlackRock Fund Advisors (1.95M shares).
This table shows the top 504 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.